The FTC issued a final order that bars the POM marketers from making any future claims unless it is supported by two randomized, well-controlled, human clinical trials. It also prohibits the misrepresentation of any scientific evidence to support its claims.
POM Wonderful said it will appeal the ruling in federal court.
"This order ignores what $35 million of peer-reviewed scientific research, centuries of traditional medicine and plain common sense have taught us: antioxidant-rich pomegranate products are good for you," the company said in a statement.
It said that with the ruling, the FTC is holding food companies to the same standards as pharmaceutical makers, a move it said will stifle research by the food industry.